Pulse Biosciences, Inc.
PLSE- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001625101
In the last 90 days, Pulse Biosciences, Inc. insiders filed 2 open-market purchases and 0 sales; 105 institutions reported holding it in 13F filings for Q2 2026, worth $297.0M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Pulse Biosciences, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 29
- −1 vs. Q3 2022
- Shares held
- 2.46M
- +83.0K (+3.5%) vs. Q3 2022
- Total value
- $6.81M
- +$1.35M (+24.7%) vs. Q3 2022
- New holders
- 6
- 9 more added
- Sold out
- 7
- 6 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PLSE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 105 | $297.0M |
| Q1 2026 | 96 | $167.6M |
| Q4 2025 | 82 | $86.9M |
| Q3 2025 | 84 | $103.5M |
| Q2 2025 | 86 | $90.3M |
| Q1 2025 | 84 | $91.7M |
| Q4 2024 | 73 | $103.9M |
| Q3 2024 | 72 | $98.4M |
| Q2 2024 | 57 | $54.1M |
| Q1 2024 | 61 | $41.4M |
| Q4 2023 | 50 | $53.4M |
| Q3 2023 | 43 | $15.6M |
| Q2 2023 | 45 | $26.1M |
| Q1 2023 | 27 | $8.06M |
| Q4 2022 | 29 | $6.81M |
| Q3 2022 | 31 | $5.61M |
| Q2 2022 | 44 | $4.66M |
| Q1 2022 | 55 | $20.5M |
| Q4 2021 | 48 | $60.3M |
| Q3 2021 | 55 | $88.9M |
| Q2 2021 | 54 | $51.7M |
| Q1 2021 | 58 | $76.9M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Pulse Biosciences, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 768,740 | $2.13M | 0.00% | −558−0.1% | Reduced |
| Vanguard Group Inc | 564,774 | $1.56M | 0.00% | +301+0.1% | Added |
| BlackRock Inc. | 223,699 | $619.6K | 0.00% | +748+0.3% | Added |
| Griffin Asset Management, Inc. | 175,893 | $487.2K | 0.07% | +90,059+104.9% | Added |
| Geode Capital Management, LLC | 139,557 | $386.0K | 0.00% | +6,388+4.8% | Added |
| Westside Investment Management, Inc. | 138,609 | $383.0K | 0.00% | −6,114−4.2% | Reduced |
| Northern Trust Corp | 73,780 | $204.4K | 0.00% | −390−0.5% | Reduced |
| State Street Corp | 68,101 | $188.6K | 0.00% | +17,400+34.3% | Added |
| Advisor Group Holdings, Inc. | 67,310 | $186.7K | 0.00% | +18,079+36.7% | Added |
| Millennium Management LLC | 45,045 | $125.0K | 0.00% | −13,606−23.2% | Reduced |
| State of Wisconsin Investment Board | 39,300 | $108.9K | 0.00% | −25,100−39.0% | Reduced |
| Tiaa, FSB | 27,298 | $75.6K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 24,565 | $68.0K | 0.00% | +24,565 | New |
| WealthTrust Axiom LLC | 21,500 | $59.6K | 0.02% | +21,500 | New |
| Levin Capital Strategies, L.P. | 19,939 | $55.2K | 0.01% | 00.0% | Unchanged |
| Morgan Stanley | 19,400 | $53.7K | 0.00% | +2,364+13.9% | Added |
| Susquehanna International Group, LLP | 13,650 | $37.8K | 0.00% | +13,650 | New |
| Wells Fargo & Company | 10,551 | $29.2K | 0.00% | +2,292+27.8% | Added |
| Simplex Trading, LLC | 9,202 | $25.0K | 0.00% | +9,202 | New |
| Ten Capital Wealth Advisors, LLC | 2,000 | $5.54K | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 2,000 | $5.44K | 0.00% | +2,000 | New |
| CWM, LLC | 1,050 | $3.00K | 0.00% | 00.0% | Unchanged |
| Osterweis Capital Management Inc | 1,000 | $2.77K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 757 | $2.10K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 835 | $2.00K | 0.00% | +733+718.6% | Added |
| Barclays PLC | 201 | $557 | 0.00% | −16−7.4% | Reduced |
| Steward Partners Investment Advisory, LLC | 178 | $493 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 12 | $0 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 160 | $0 | 0.00% | +160 | New |
| Ergoteles LLC | 0 | $0 | 0.00% | −37,096−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −12,274−100.0% | Sold out |
| Alpine Global Management, LLC | 0 | $0 | 0.00% | −12,274−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −11,657−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −4,500−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −2,742−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Spotlight Asset Group, Inc. | – | – | – | – | Not filed |